Please note that a publication can be assigned to several endpoints, i.e. the sum of publications from the individual thematic points and subpoints can be greater than the total sum of actual publications.
Authors | Year | Exposed system | Parameters | Magnetic flux density/field strength |
---|---|---|---|---|
Blackman CF et al. | 1993 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | electric field, magnetic field, 50/60 Hz | 0 nT–10.2 µT |
McFarlane EH et al. | 2000 | intact cell/cell culture, PC-12 cells (pheochromocytoma cell line from rat adrenal gland) | magnetic field, 50/60 Hz | 4.35–15.8 µT |
Blackman CF et al. | 1993 | intact cell/cell culture, PC-12D cells (subline of the PC-12 cell line, derived from pheochromocytoma cells from the rat adrenal medulla) | magnetic field, 50/60 Hz | 0.4–40 µT |
Santoro N et al. | 1997 | intact cell/cell culture, Raji cells (human Burkitt lymphoma B lymphocyte cell line) | magnetic field, 50/60 Hz | 2 mT |
Lisi A et al. | 2000 | intact cell/cell culture, Raji cells (human Burkitt lymphoma B lymphocyte cell line) | magnetic field, 50/60 Hz | 1 mT |
Girasole M et al. | 2001 | intact cell/cell culture, Raji cells (human Burkitt lymphoma B lymphocyte cell line) | magnetic field, 50/60 Hz | 2 mT |
Sulpizio M et al. | 2011 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 1 mT |
Hasanzadeh H et al. | 2014 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 2 mT |
Rezaie-Tavirani M et al. | 2017 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz | 0.5–1 mT |
Aparicio-Bautista DI et al. | 2022 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | magnetic field, 50/60 Hz, low frequency | - |
Calabrò E et al. | 2020 | intact cell/cell culture, SH-SY5Y (human neuroblastoma cell line) | 50/60 Hz, magnetic field | - |
Schmidt-Rohlfing B et al. | 2008 | intact cell/cell culture, chondrocytes (from human articular cartilage of osteoarthritic knee joints) | magnetic field, low frequency, signals/pulses, 50/60 Hz, electrotherapy | 2 mT |
Verdugo-Diaz L et al. | 2002 | intact cell/cell culture, chromaffin cells (from neonatal rats) | magnetic field, 50/60 Hz | 700 µT |
Drucker-Colin R et al. | 1994 | intact cell/cell culture, chromaffin cells (from postnatal Wistar rat adrenal medulla) | magnetic field, 50/60 Hz, co-exposure | 700 µT |
Zhang L et al. | 1997 | intact cell/cell culture, chromaffin cells (from rat adrenal medulla) | magnetic field, 50/60 Hz | 1 mT |
Anaya M et al. | 2021 | intact cell/cell culture, fungal strains (<i>Aspergillus niger</i> Tiegh., <i>Penicillium citrinum</i> Thom., <i>Cladosporium cladosporioides</i> Fresen.) | 50/60 Hz, magnetic field | 1–5 mT |
Łach K et al. | 2021 | intact cell/cell culture, human adipose tissue mesenchymal stem cells (AT-MSCs) | 50/60 Hz, magnetic field | - |
Sendera A et al. | 2024 | intact cell/cell culture, human adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, low frequency | - |
Wu X et al. | 2018 | intact cell/cell culture, human amniotic epithelium cells (FL), rat pheochromocytoma cells (PC12) | magnetic field, 50/60 Hz | 0.4 mT |
Nafziger J et al. | 1997 | intact cell/cell culture, human bone marrow cells | magnetic field, 50/60 Hz | 10 µT–1 mT |
Cho H et al. | 2012 | intact cell/cell culture, human bone marrow-derived mesenchymal stem cells (hBM-MSCs) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Naghibzadeh M et al. | 2020 | intact cell/cell culture, human dermal fibroblasts | magnetic field, 50/60 Hz | 1–5 mT |
Bai WF et al. | 2012 | intact cell/cell culture, human epidermal stem cells of the foreskin | magnetic field, 50/60 Hz | 5 mT |
Milani M et al. | 2001 | intact cell/cell culture, human lymphocytes | magnetic field, 50/60 Hz | 50 µT |
Yan J et al. | 2010 | intact cell/cell culture, human mesenchymal stem cells | magnetic field, low frequency, 50/60 Hz | 20 mT |
Santini MT et al. | 2003 | intact cell/cell culture, human osteosarcoma cell lines (MG-63 and Saos-2) | magnetic field, 50/60 Hz | 500 µT |
Delle Monache S et al. | 2008 | intact cell/cell culture, human vein endothelial cells (HUVEC) | magnetic field, low frequency, 50/60 Hz | 1 mT |
Gomez-Ochoa I et al. | 2011 | intact cell/cell culture, mononuclear cells (from human peripheral blood) | magnetic field, signals/pulses, 50/60 Hz, electrotherapy | 2.25 mT |
Soda A et al. | 2008 | intact cell/cell culture, mouse osteoblast-like MC3T3-E1 cells | magnetic field, 50/60 Hz | 3 mT |
Hilz FM et al. | 2014 | intact cell/cell culture, primary articular chondrocytes (from calf fetlock joints) | magnetic field, 50/60 Hz, co-exposure | 1–3 mT |
Pasi F et al. | 2016 | intact cell/cell culture, primary human dermal fibroblasts | magnetic field, 50/60 Hz, therapeutic/medical device | 0.25–1.6 mT |
Moraveji M et al. | 2021 | intact cell/cell culture, rat adipose-derived mesenchymal stem cells | magnetic field, 50/60 Hz, signals/pulses, also other exposures without EMF, co-exposure | - |
Liu C et al. | 2013 | intact cell/cell culture, rat bone marrow mesenchymal stromal cells | magnetic field, 50/60 Hz | 1 mT |
Amirahmadi F et al. | 2023 | intact cell/cell culture, rat bone marrow-derived stem cells | magnetic field, 50/60 Hz, low frequency, also other exposures without EMF, co-exposure | - |
Marron MT et al. | 1988 | intact cell/cell culture, slime mold amoebae <i>Physarum polycephalum</i> | electric field, magnetic field, 50/60 Hz | 100 µT |
Baciu C et al. | 2001 | intact cell/cell culture, yeast (<i>Saccharomyces cerevisiae</i>) | magnetic field, signals/pulses, 50/60 Hz, electroporation | 0.5–12 mT |
Gobba F et al. | 2003 | invertebrate, mussel/<i>Mytilus galloprovincialis</i> | magnetic field, 50/60 Hz | 300 µT |
Malagoli D et al. | 2003 | invertebrate, mussel/<i>Mytilus galloprovincialis</i>, whole body | magnetic field, 50/60 Hz | 300–600 µT |
Santini MT et al. | 2006 | small, proliferating MG-63 spheroids | magnetic field, 50/60 Hz | 1 mT |
This website uses cookies to provide you the best browsing experience. By continuing to use this website you accept our use of cookies.